Former FDA Commissioner Dr. Scott Gottlieb gives his take on the most recent Medicare drug price negotiations.
- Former FDA commissioner on Medicare drug price negotiation ( Download)
- Former FDA Commissioner Dr. Scott Gottlieb on Mpox outbreak, Medicare drug price negotiations ( Download)
- Medicare drug price negotiations will shrink the focus of R&D pursuits, says Dr. Scott Gottlieb ( Download)
- Scott Gottlieb on why he thinks government should not set drug price controls ( Download)
- Dr. Scott Gottlieb on the Medicare drug cost battle as Pres. Biden targets drug prices ( Download)
- Fmr. FDA Commissioner weighs in on Medicare's involvement in GLP-1 prices ( Download)
- Former FDA Commissioner Scott Gottlieb on ensuring drug prices don't widen the income gap ( Download)
- FDA Commissioner Gottlieb on lowering prescription drug costs ( Download)
- U.S. drug shortage a “long standing problem,” ex-FDA Commissioner Dr. Scott Gottlieb says #shorts ( Download)
- Former FDA Commissioner Scott Gottlieb speaks at The National Press Club ( Download)
- Ep 92 #360it : Medicare Drug Price Negotiation: How Will it Affect Patient Access ( Download)
- HHS secretary on Medicare drug pricing, gender definitions ( Download)
- Medicare’s New Drug Price Negotiation Program: 2023 Health Policy Speaker Series ( Download)
- Fmr. FDA Commissioner Dr. Scott Gottlieb on the opportunities for A.I. in healthcare ( Download)
- NHC Briefing on Medicare Drug Price Negotiation Program Implementation ( Download)
